Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Reported Basic Consolidated EPS Of $-1.4765 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) for the period ended 2015-12-31 was $-1.4765. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-1.4765.

EPS from continuing operations

Coming to basic EPS from continuing operations, Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) reported $-1.4765 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-1.4765.

EPS contribution from parent

For the annual period ended 2015-12-31, Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) received basic EPS of $-1.4765 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-1.4765.

Basic net EPS

For the annual period ended 2015-12-31, Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) reported basic net EPS of $-1.48. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-1.48.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-1.4765. For the quarter ended 2015-12-31, consolidated diluted EPS was $-1.4765.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-1.4765 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-1.4765.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-1.48. For the quarterly period ended 2015-12-31, net diluted EPS was $-1.48.

Diluted EPS from parent

From the parent company, Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) received diluted EPS of $-1.4765 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-1.4765.

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) posted net basic EPS reading of $-1.4288 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-1.4288 was for the quarter ended 2015-12-31.

Net diluted EPS for Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) for the annual period ended 2015-12-31 was $-2. The company also reported net diluted EPS reading of $-2 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 32.865 while for the quarter ended 2015-12-31 is 32.865.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 32.865 while for the quarter ended 2015-12-31 is 32.865.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 46 times, 1 visits today)